Abstract
The aims of this work were to measure the entrance and exit dose for patient treated for head and neck tumors. The target absorbed dose was determined from the exit and entrance dose measurement. Twenty patients were evaluated. The results were compared to the calculated values and the midline dose was determinate and compared with the prescribed dose. 80 entrance doses and 80 exit doses measurements were performed. The average difference from expected values was 1.93% for entrance dose (SD 1.92%) and –0.34% for exit dose (SD 4.1%). The target absorbed dose differed from prescribed dose values by 2.94% (1.97%) for the results using the Noel method and 3.34% (SD: 2.29%) with the Rizzotti method. The total uncertainty budget in the measurement of the absorbed entrance and exit dose with diode, including diode reading, correction factors and diode calibration coefficient, is determined as 3.02% (1 s). Simple in vivo dose measurements are an additional safeguard against major setup errors and calculation or transcription errors that were missed during pre-treatment chart check.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
